Insufficient scRNA-seq data for expression of E2F7 at single-cell level.
Insufficient scRNA-seq data for expression of E2F7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 97% | 389.92 | 1750 / 1809 | 86% | 6.91 | 405 / 472 |
lung | 86% | 91.81 | 496 / 578 | 65% | 6.10 | 753 / 1155 |
esophagus | 43% | 144.40 | 625 / 1445 | 96% | 13.71 | 175 / 183 |
bladder | 62% | 66.43 | 13 / 21 | 76% | 5.64 | 382 / 504 |
intestine | 52% | 66.89 | 500 / 966 | 82% | 4.69 | 430 / 527 |
stomach | 48% | 59.12 | 172 / 359 | 83% | 5.18 | 236 / 286 |
uterus | 15% | 13.26 | 26 / 170 | 91% | 12.86 | 416 / 459 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.89 | 45 / 45 |
spleen | 93% | 95.23 | 223 / 241 | 0% | 0 | 0 / 0 |
ovary | 22% | 15.52 | 39 / 180 | 63% | 3.50 | 272 / 430 |
breast | 30% | 14.70 | 139 / 459 | 53% | 3.05 | 597 / 1118 |
pancreas | 40% | 22.02 | 132 / 328 | 33% | 1.52 | 59 / 178 |
prostate | 67% | 48.17 | 165 / 245 | 4% | 0.18 | 19 / 502 |
lymph node | 0% | 0 | 0 / 0 | 52% | 2.88 | 15 / 29 |
brain | 16% | 11.82 | 435 / 2642 | 35% | 2.35 | 245 / 705 |
heart | 43% | 23.13 | 369 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 37% | 17.67 | 96 / 258 | 5% | 0.25 | 11 / 230 |
peripheral blood | 41% | 690.54 | 380 / 929 | 0% | 0 | 0 / 0 |
thymus | 25% | 11.34 | 162 / 653 | 13% | 1.10 | 77 / 605 |
kidney | 22% | 16.20 | 20 / 89 | 8% | 0.42 | 69 / 901 |
liver | 14% | 11.79 | 31 / 226 | 15% | 0.74 | 62 / 406 |
adipose | 24% | 11.85 | 290 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 21% | 8.58 | 279 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.37 | 8 / 80 |
muscle | 1% | 0.40 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0032466 | Biological process | negative regulation of cytokinesis |
GO_0060718 | Biological process | chorionic trophoblast cell differentiation |
GO_0032877 | Biological process | positive regulation of DNA endoreduplication |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0001890 | Biological process | placenta development |
GO_0060707 | Biological process | trophoblast giant cell differentiation |
GO_0002040 | Biological process | sprouting angiogenesis |
GO_0006977 | Biological process | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0070365 | Biological process | hepatocyte differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0001217 | Molecular function | DNA-binding transcription repressor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | E2F7 |
Protein name | E2F transcription factor 7 Transcription factor E2F7 (E2F-7) Transcription factor E2F7 |
Synonyms | |
Description | FUNCTION: Atypical E2F transcription factor that participates in various processes such as angiogenesis, polyploidization of specialized cells and DNA damage response. Mainly acts as a transcription repressor that binds DNA independently of DP proteins and specifically recognizes the E2 recognition site 5'-TTTC[CG]CGC-3'. Directly represses transcription of classical E2F transcription factors such as E2F1. Acts as a regulator of S-phase by recognizing and binding the E2-related site 5'-TTCCCGCC-3' and mediating repression of G1/S-regulated genes. Plays a key role in polyploidization of cells in placenta and liver by regulating the endocycle, probably by repressing genes promoting cytokinesis and antagonizing action of classical E2F proteins (E2F1, E2F2 and/or E2F3). Required for placental development by promoting polyploidization of trophoblast giant cells. Also involved in DNA damage response: up-regulated by p53/TP53 following genotoxic stress and acts as a downstream effector of p53/TP53-dependent repression by mediating repression of indirect p53/TP53 target genes involved in DNA replication. Acts as a promoter of sprouting angiogenesis, possibly by acting as a transcription activator: associates with HIF1A, recognizes and binds the VEGFA promoter, which is different from canonical E2 recognition site, and activates expression of the VEGFA gene. Acts as a negative regulator of keratinocyte differentiation. . |
Accessions | ENST00000416496.6 [Q96AV8-2] ENST00000550669.5 H0YHW2 H0YIF4 ENST00000547316.1 ENST00000551058.1 ENST00000322886.12 [Q96AV8-1] F8VXV5 Q96AV8 F8VSE7 ENST00000552907.5 |